BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//University of Manitoba//UMFOD Calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:6a399ca67216b@umanitoba.ca
SUMMARY:Multiple Sclerosis Research Program - Clinical Trial Award - Internal Deadline
DESCRIPTION:Multiple Sclerosis Research Program - Clinical Trial Award\n\nThe Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $4M USD to fund approximately two MSRP CTA-FL1 applications and one MSRP CTA-FL2 application with total cost caps of $1M USD for the CTA-FL1 and $2M USD for the CTA-FL2. The maximum period of performance is 3 years for the CTA-FL1 and 4 years for the CTA-FL2.\n\n\nInternal Application Deadline: Jul 23, 2026 \n\nUMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4317\n\nProgram URL: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=713102\nInternal Deadline
X-ALT-DESC;FMTTYPE=text/html:Multiple Sclerosis Research Program - Clinical Trial Award
The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $4M USD to fund approximately two MSRP CTA-FL1 applications and one MSRP CTA-FL2 application with total cost caps of $1M USD for the CTA-FL1 and $2M USD for the CTA-FL2. The maximum period of performance is 3 years for the CTA-FL1 and 4 years for the CTA-FL2.
Internal Application Deadline: Jul 23\, 2026
UMFOD Details: https://research.ad.umanitoba.ca/mrt/pubapp/umfo_view.php?id=4317
Program URL: https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=713102
DTSTART:20260723T083000
DTEND:20260723T093000
BEGIN:VALARM
TRIGGER:-P2D
ACTION:DISPLAY
DESCRIPTION:Reminder for Multiple Sclerosis Research Program - Clinical Trial Award
END:VALARM
END:VEVENT
END:VCALENDAR